Abstract:More than 90% of under one year old infants with acute megakaryoblastic leukemia (AMKL) have chromosome translocation t(1;22)(p13;q13) with RBM15 fused to MKL1. RBM15 encodes an RNA binding protein important for hematopoietic stem cell self-renewal and differentiation. In agreement with its roles in AMKL, RBM15 is required for normal megakaryocyte differentiation. We found that higher expression of PRMT1 (Protein Arginine Methyltransferase) is commonly seen in M7 leukemia patient samples than other types of myeloid leukemia and that RBM15 is a bona fide methylation target for PRMT1. Using mass spectrometry analysis, we mapped the PRMT1 mediated mono-methylated site. The enzymatic activity of the PRMT1 V2 isoform is required for RBM15 degradation, as both shRNA molecules knocking down PRMT1 and small chemical PRMT1 inhibitors stabilize the RBM15 protein. Mutation of the methylation site to lysine blocks the ubiquitylation mediated degradation. Thus the degradation is a methylation dependent process. We identified the E3 ligase responsible for the degradation. Down-regulation of the RBM15 protein changes the isoform ratio of genes including GATA1 critical megakaryocyte differentiation. We found that RBM15 regulates its interaction with SF3B1A in methylation dependent manner during alternative splicing of GATA1 pre-mRNA. Thus, via methylation triggered RBM15 degradation, the megakaryocyte progenitor cells maintain a delicate balance between differentiation and proliferation by keeping the proper ratio of GATA1s and GATA1-full length mRNA. SF3B1A has been shown to be mutated in myeloid dysplasia syndrome and in several different types of leukemia. Methylation by PRMT1 links the two types of leukemic genes into a single pathway. Our results imply that targeting PRMT1/RBM15 pathway might be a potential therapy for AMKL and other blood malignancies.

Methylation of Ribosomal Protein S10 by Protein-arginine Methyltransferase 5 Regulates Ribosome Biogenesis*

The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond

Versatility of PRMT5-induced methylation in growth control and development

PRMT5 in gene regulation and hematologic malignancies

Proteomics Profiling of Arginine Methylation Defines PRMT5 Substrate Specificity

NML-mediated rRNA base methylation links ribosomal subunit formation to cell proliferation in a p53-dependent manner

The Methylation Induced by Protein Arginine Methyltransferase 5 Promotes Tumorigenesis and Progression of Lung Cancer.

PRMT5 confers lipid metabolism reprogramming, tumour growth and metastasis depending on the SIRT7-mediated desuccinylation of PRMT5 K387 in tumours

METTL18-mediated histidine methylation of RPL3 modulates translation elongation for proteostasis maintenance

Arginine Methylation Of Rbm15 By Prmt1 Controls Alternative Splicing Of Genes Involved In Megakaryocyte Differentiation

The methylation induced by protein arginine methyltransferase 5 promotes tumorigenesis and progression of lung cancer

Regulation of RORα Stability through PRMT5-Dependent Symmetric Dimethylation

PRMT1 methylates METTL14 to modulate its oncogenic function

A systematic survey of PRMT interactomes reveals the key roles of arginine methylation in the global control of RNA splicing and translation

Dysregulation of arginine methylation in tumorigenesis

Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5)

Molecular basis for substrate recruitment to the PRMT5 methylosome

Ribosome 18S m6A Methyltransferase METTL5 Promotes Translation Initiation and Breast Cancer Cell Growth

Oligomerization of protein arginine methyltransferase 1 and its effect on methyltransferase activity and substrate specificity

Protein arginine methylation of non-histone proteins and its role in diseases.

PRMT5 regulates the NAD-SIRT1-p53 signal axis by affecting the methylation of CD38 at R58 to promote malignant tumor cell proliferation